Hendrik Van Deventer

Hendrik Van Deventer serves as Professor of Medicine in the Department of Medicine, Division of Hematology at the University of North Carolina at Chapel Hill School of Medicine. He maintains an active clinical practice at UNC Hospitals Adult Oncology Clinics within the N.C. Basnight Cancer Hospital, specializing in Malignant Hematology. His professional profile spans both laboratory research and clinical oncology practice.

Dr. Van Deventer's educational background includes undergraduate studies at Davidson College, an MS from the University of North Carolina at Chapel Hill, medical school at Virginia Commonwealth University (Medical College of Virginia), residency in Internal Medicine at the University of Michigan, and fellowship training in Hematology/Oncology at UNC Chapel Hill.

His research career began in 2000 with laboratory investigations into the role of chemokines in tumor metastases, particularly focusing on CCR5-/- mice models and fibrocyte contributions to cancer progression. Over 14 years, his lab demonstrated how fibrocytes increase metastases and validated these findings in myeloma models. More recently, he has shifted toward clinical research through collaborations with the UNC School of Pharmacy, focusing on clinically relevant questions often overlooked in larger trials. He considers his main accomplishment to be creating research opportunities for UNC pharmacy residents with publication goals.

Analysis of his publications reveals a research trajectory evolving from basic laboratory science on tumor metastases to clinical oncology applications. His recent work spans hematologic malignancies, immunotherapy approaches for leukemia, breast cancer vaccine development, and methodological improvements in clinical laboratory testing. The publications reflect strong collaboration across disciplines including hematology, oncology, immunology, and clinical chemistry.

Dr. Van Deventer maintains an active clinical practice as evidenced by his 4.9 out of 5 patient satisfaction rating based on 210 reviews, with patients particularly noting his concern for their questions, inclusion in decision-making, and clear explanations of conditions and treatments.

He mentors pharmacy residents in clinical research and maintains collaborations across multiple departments at UNC. His clinical work focuses on malignant hematology patients at the N.C. Basnight Cancer Hospital where he sees patients in the Adult Oncology Clinics.